Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00759369 · ClinicalTrials.gov registry record · NA
Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
A NA study, sponsored by University of Kansas.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT00759369 is a NA study that has completed, run by University of Kansas. The registered enrollment target is 11 participants.
The verdict
NCT00759369, a NA study, has completed, sponsored by University of Kansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
Autosomal dominant polycystic kidney disease (ADPKD) is the most common single gene disorder that is potentially fatal. ADPKD is caused by mutations in either of two genes (PKD1, PKD2). Cysts begin to develop primarily in renal collecting tubules in utero and continue to form and expand throughout the patient's life. One of the goals of the study is to formulate a water prescription for use in clinical trials to determine the effect of sustained water diuresis on the progression of ADPKD.
Interventions
- OTHER Water prescription
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2008-09 |
| Est. Completion | 2009-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00759369
The ClinicalTrials.gov registry entry for NCT00759369 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Water prescription is the first listed.
NCT00759369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00759369 about?
NCT00759369 is a clinical study titled "Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD)". Autosomal dominant polycystic kidney disease (ADPKD) is the most common single gene disorder that is potentially fatal. ADPKD is caused by mutations in either of two genes (PKD1, PKD2). Cysts begin to develop primarily in renal collecting tubules in utero and continue to form and expand throughout t...
What is the current status of trial NCT00759369?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2008-09. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00759369?
The interventions under investigation include: Water prescription (OTHER).
Who is sponsoring clinical trial NCT00759369?
This trial is sponsored by University of Kansas, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.